Advanced technology. Exacting standards.

Company Overview

Implant Sciences Corporation (AMEX:IMX) develops and commercializes explosives trace detection (ETD) solutions for transportation, critical infrastructure, and ports and borders security, as well as force protection and emergency response.

Founded in 1984, Implant Sciences has a rich history of developing leading technologies in several markets including: ion implantation services for the semiconductor industry; brachytherapy seeds for prostate cancer treatment; and sophisticated coatings to reduce wear on orthopedic joint replacements.

By the end of 2008, as part of the company’s restructuring towards a single business focus, the medical and semiconductor businesses and associated assets were fully divested. The company today is a pure play in global Security, Safety, and Defense (SS&D) markets.

Come see us at TranSec World Expo
June 3-4, 2009
At RAI Amsterdam

 

Press Center

4/13/2009
Implant Sciences' QS-H300 Evaluated by TSA for Use in Air Cargo Screening

3/30/2009
Implant Sciences Receives Final Listing Determination Letter

3/30/2009
Implant Sciences Announces Settlement in Evans Litigation

2/19/2009
Implant Sciences Corporation Announces Second Quarter Results for Fiscal 2009

2/6/2009
Implant Sciences Receives Listing Determination Letter

01/06/09
Implant Sciences Appoints
Glenn D. Bolduc as President
and Chief Executive Officer